Stay updated with breaking news from Hyperfine Daily. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Hyperfine (NASDAQ:HYPR – Get Rating) is scheduled to be announcing its earnings results after the market closes on Thursday, May 11th. Analysts expect the company to announce earnings of ($0.16) per share for the quarter. Investors that wish to register for the company’s conference call can do so using this link. Hyperfine Stock Down 3.4 […]
Hyperfine (NASDAQ:HYPR – Get Rating) and Cutera (NASDAQ:CUTR – Get Rating) are both small-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their profitability, dividends, risk, institutional ownership, valuation, analyst recommendations and earnings. Insider & Institutional Ownership 27.7% of Hyperfine shares are owned by […]
Hyperfine (NASDAQ:HYPR – Get Rating) had its price target cut by B. Riley from $3.50 to $2.50 in a research report released on Wednesday, The Fly reports. They currently have a buy rating on the stock. B. Riley also issued estimates for Hyperfine’s Q1 2023 earnings at ($0.16) EPS, Q2 2023 earnings at ($0.16) EPS, […]
Hyperfine, Inc. (NASDAQ:HYPR – Get Rating) – Equities research analysts at B. Riley boosted their FY2023 earnings per share (EPS) estimates for Hyperfine in a research note issued to investors on Tuesday, March 21st. B. Riley analyst N. Chatterji now anticipates that the company will earn ($0.67) per share for the year, up from their […]